Cochrane  on October 11, 2024

Balanced News   View All Sources

Botulinum toxin for the management of bruxism: an overview of reviews protocol

science

Introduction Bruxism is characterised by a repetitive activity in the masticatory muscles that involves teeth clenching or grinding and/or forceful mandibular movements. Its management is typically initiated when individuals start experiencing the adverse effects of the condition. One of the available intervention forms is the administration of botulinum toxin type A (BoNT-A). Numerous systematic reviews have addressed the use of BoNT-A to manage bruxism; however, the results are controversial. The current overview aims to determine BoNT-A’s effectiveness for managing bruxism in relation to placebo, the absence of treatment or alternative interventions in the adult population. Methods and analysis This study will include systematic reviews (SRs), with or without meta-analysis, aiming to evaluate the efficacy of BoNT-A ...

BMJ     Oct 11, 2024